NCT05554367 2026-03-18Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting199 enrolled
NCT01363232 2020-10-05Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor PatientsArray BioPharmaPhase 1 Completed89 enrolled